the value of ipi/nivo in treating metastatic melanoma
Published 6 years ago • 1.4K plays • Length 7:08Download video MP4
Download video MP3
Similar videos
-
2:45
long-term outcomes of nivo vs. nivo/ipi in melanoma brain metastases: abc trial data
-
1:03
dr. long on nivolumab/ipilimumab in patients with melanoma brain metastases
-
7:00
metastatic melanoma: the immunotherapy approach
-
3:24
ipilimumab side effect management in melanoma
-
1:28
dr. jeffery s. weber on sequencing of nivolumab, ipilimumab in metastatic melanoma
-
5:55
considering chemotherapy’s value in melanoma
-
4:25
the phenomenon of immunotherapy in melanoma
-
0:59
dr. luke on treatment options in metastatic melanoma
-
1:14
dr. pavlick on importance of immunotherapy in metastatic melanoma
-
7:28
metastatic melanoma brain metastases
-
6:21
new long-term data 'clearly favor' combination ipilimumab/nivolumab in melanoma
-
8:10
novel therapies in metastatic melanoma
-
3:59
checkmate 067 - combined nivolumab and ipilimumab
-
3:34
intralesional therapy for metastatic melanoma
-
8:42
sequencing decisions and multidisciplinary care in metastatic melanoma
-
1:47
dr. sznol on combining nivolumab and ipilimumab for the treatment of advanced melanoma
-
9:07
optimal treatment of metastatic melanoma at progression
-
10:05
nivolumab alone superior to ipilimumab alone in advanced melanoma
-
5:28
novel combinations for metastatic melanoma